Full-Time
Medical Writer/Senior Medical Writer
Posted on 4/23/2024
Develops radiopharmaceuticals for oncology, rare diseases
Senior, Expert
Remote in USA
- Bachelor of Science in a science or related field
- Advance degree preferred
- 8+ years of experience in pharmaceutical industry with 5+ years of experience in regulatory writing required for Medical Writer; 8+ years' experience in regulatory writing required for Senior Medical Writer
- Strong understanding of drug development, clinical study design, regulations (CFR, FDA, EMA, and ICH guidelines), and scientific principles
- Experience writing clinical protocols, Investigator Brochures, clinical study reports, eCTD clinical summaries, and integrated summaries of safety and efficacy
- Strong command of English language, grammar, style, logical progression
- Experience and proficiency with document templates, document toolbars and proper version control
- Lead the compilation, writing, and editing of high-quality regulatory documents and reports (primarily clinically oriented) including CSRs, IBs, safety narratives, safety reports, ISS, ISE, and eCTD summary documents for IND, NDA, MAA, BLA applications and amendments
- Interpret data, search and analyze published literature, define problems, establish facts, draw valid scientific conclusions, propose solutions or corrective actions, and compose text accordingly
- Work with colleagues, physicians, clinical scientists, and statisticians in a professional and organized manner to complete projects in a timely manner
- Collaborate with project teams to respond to heath authority questions and requests
- Develop and update pertinent SOPs, processes, templates, style guides, and manuals, as needed
- Maintain knowledge to enable ongoing execution of function as medical writing expert. Maintain working knowledge of the Telix clinical development pipeline
Telix Pharmaceuticals Limited is at the forefront of enhancing oncological and rare disease management through their specialized radiopharmaceuticals that aid both in diagnosis and therapy. The company's focus on developing targeted radiation products for a range of cancers - including prostate, kidney, brain, and hematologic types - ensures that they are a leader in personalized healthcare solutions. By securing global regulatory approvals and establishing a reliable supply chain, they offer a robust environment for professional growth and innovation within the pharmaceutical industry.
Company Stage
Grant
Total Funding
$63.5M
Headquarters
North Melbourne, Australia
Founded
2015